2C-T-13
 |
|
 |
|
| Names | |
|---|---|
| IUPAC name
2-[4-(Methoxyethylthio)-2,5-dimethoxyphenyl]ethanamine
|
|
| Identifiers | |
207740-30-5  |
|
| 3D model (Jmol) | Interactive image |
| ChEMBL | ChEMBL123868  |
| ChemSpider | 21106228 |
|
|
|
|
| Properties | |
| C13H21NO3S | |
| Molar mass | 271.38 g/mol |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
 verify (what is ?) |
|
| Infobox references | |
2C-T-13 or 2,5-dimethoxy-4-(β-methoxyethylthio)phenethylamine is a psychedelic phenethylamine of the 2C family. It was presumably first synthesized by Alexander Shulgin and reported in his book PiHKAL (Phenethylamines i Have Known And Loved).
Contents
Chemistry[edit]
2C-T-13 is the 2 carbon homologue of Aleph-13. The full chemical name is 2-[4-(2-methoxyethylthio)-2,5-dimethoxyphenyl]ethanamine. The drug has structural properties similar to mescaline and other drugs in the 2C-T series, with the most closely related compounds being 2C-T-7 and 2C-T-21.
General information[edit]
The dosage range of 2C-T-13 is typically 25 - 40 mg and its duration is approximately 6–8 hours according to Shulgin. 2C-T-13 produces many closed-eye visuals and geometric patterns. It also produces slight visual distortion.[1]
Pharmacology[edit]
The mechanism that produces 2C-T-13's hallucinogenic and entheogenic effects has not been specifically established, however it is most likely to result from action as a 5-HT2A serotonin receptor agonist in the brain, a mechanism of action shared by all of the hallucinogenic tryptamines and phenethylamines for which the mechanism of action is known.
Dangers[edit]
The toxicity of 2C-T-13 is not well documented. 2C-T-13 is slightly less potent than 2C-T-7, but it may be expected that at higher doses it would display similar toxicity to that of other phenethylamines of the 2C-T family.
Legality[edit]
2C-T-13 is not illegal in the United States, but possession and sales of 2C-T-13 could be prosecuted under the Federal Analog Act because of its structural similarities to 2C-T-7.
As of October 31st, 2016; 2C-T-13 is a controlled substance (Schedule III) in Canada.[2]
References[edit]
- ^ Shulgin, Alexander; Ann Shulgin (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
- ^ http://gazette.gc.ca/rp-pr/p2/2016/2016-05-04/html/sor-dors72-eng.php
